Clearside Biomedical

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy.

CEO

George M. Lasezkay

CEOGeorge M. Lasezkay

Employees

Employees34

Headquarters

Alpharetta, Georgia

HeadquartersAlpharetta, Georgia

Founded

2011

Founded2011

Employees

Employees34

CLSD Key Statistics

Market cap

63.20M

Market cap63.20M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

136.57K

Average volume136.57K

High today

$1.11

High today$1.11

Low today

$1.05

Low today$1.05

Open price

$1.08

Open price$1.08

Volume

32.36K

Volume32.36K

52 Week high

$6.25

52 Week high$6.25

52 Week low

$1.03

52 Week low$1.03

CLSD Earnings

-$0.14

$0.01

$0.16

$0.31

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 10, Pre-Market

ActualExpected Nov 10, Pre-Market

Clearside Biomedical

Why Robinhood?

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. Show more

CLSD Key Statistics

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy.